Danaher Corporation (DHR) To Release FQ3 Results on October 21

Danaher Corporation (NYSE:DHR) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 23, Danaher Corporation (NYSE:DHR) announced that it will release its fiscal third-quarter results on October 21, 2025.

The company topped Wall Street estimates during its fiscal second quarter of 2025. It delivered a revenue of $5.94 billion, up 3.36% year-over-year and ahead of expectations by $100.95 million. Moreover, the EPS of $1.80 also topped estimates by $0.16. Management expects the third quarter revenue to grow by low single digits year-over-year.

Wall Street is bullish on the stock. On September 2, RBC Capital reiterated a Buy rating on Danaher Corporation (NYSE:DHR) while reducing the price target from $250 to $241. More recently, on September 22, Bank of America Securities also reiterated a Buy rating on the stock and reduced the price target from $230 to $220.

Danaher Corporation (NYSE:DHR) is a global innovator in life sciences and diagnostics. It operates in three segments: Biotechnology, Life Sciences, and Diagnostics.

While we acknowledge the potential of DHR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.